{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:20:33Z","timestamp":1793755233332,"version":"4.6.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T00:00:00Z","timestamp":1659916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T00:00:00Z","timestamp":1659916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Vulvovaginal candidiasis is an important cause of morbidity among women due to <jats:italic>Candida<\/jats:italic> species. In the last decades, resistance to azoles, first-line antifungals has increased. One molecular mechanism of azole resistance by <jats:italic>Candida<\/jats:italic> involves mutations in the <jats:italic>ERG11<\/jats:italic> gene encoding lanosterol 14-\u03b1-demethylase, the target enzyme. This study was conducted to identify the clinical <jats:italic>Candida<\/jats:italic> species associated in vulvovaginal candidiasis; to determine the rate of antifungal resistance among <jats:italic>Candida albicans<\/jats:italic> isolates and to determine mutated <jats:italic>ERG11<\/jats:italic> gene at Saint Camille Hospital in Ouagadougou, Burkina Faso.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Antifungals susceptibility were performed using Kirby\u2013Bauer disk diffusion method. <jats:italic>ERG11<\/jats:italic> gene was detected using conventional PCR in <jats:italic>C. albicans<\/jats:italic> isolates resistant to at least one azole.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Out of 262 clinical strains isolated, <jats:italic>C. albicans<\/jats:italic> accounted for 59.90%, followed by <jats:italic>Candida glabrata<\/jats:italic> 27.86%, <jats:italic>Candida famata<\/jats:italic> 7.25%, <jats:italic>Candida tropicalis<\/jats:italic> 3.05% and <jats:italic>Saccharomyces cerevisiae<\/jats:italic> 1.91%. Resistance rate of fluconazole to <jats:italic>C. albicans<\/jats:italic> was 59.54%. <jats:italic>ERG11<\/jats:italic> gene was found in 9.79% of 92 <jats:italic>C. albicans<\/jats:italic> strains resistant to azoles.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This detection of mutated <jats:italic>ERG11<\/jats:italic> gene in <jats:italic>C. albicans<\/jats:italic> is the first in Burkina Faso and may be a cause of azole resistance in recurrent <jats:italic>Candida<\/jats:italic> vulvovaginitis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07619-5","type":"journal-article","created":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T13:03:19Z","timestamp":1659963799000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["First detection of mutated ERG11 gene in vulvovaginal Candida albicans isolates at Ouagadougou\/Burkina Faso"],"prefix":"10.1186","volume":"22","author":[{"given":"Essi Etonam","family":"Dovo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9odora Mahouk\u00e8d\u00e8","family":"Zohoncon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sessi Frida","family":"Tovo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge Th\u00e9ophile","family":"Soubeiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle Touwendpoulimd\u00e9","family":"Kiendrebeogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert Th\u00e9ophane","family":"Yonli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogomenona Alice","family":"Ouedraogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amana M\u00e8tuor","family":"Dabire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florencia Wendkuuni","family":"Djigma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle Wendyam","family":"Nadembega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Belemgnegre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Ouedraogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorcas","family":"Obiri-Yeboah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Simpore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,8]]},"reference":[{"key":"7619_CR1","doi-asserted-by":"publisher","DOI":"10.3109\/1040841X.2015.1091805","author":"B Gon\u00e7alves","year":"2016","unstructured":"Gon\u00e7alves B, Ferreira C, Alves CT, Henriques M, Azeredo J, Silva S. Vulvovaginal candidiasis: epidemiology, microbiology and risk factors. Crit Rev Microbiol. 2016. https:\/\/doi.org\/10.3109\/1040841X.2015.1091805.","journal-title":"Crit Rev Microbiol"},{"key":"7619_CR2","doi-asserted-by":"publisher","first-page":"Doc14","DOI":"10.3205\/dgkh000320","volume":"14","author":"P Behzadi","year":"2019","unstructured":"Behzadi P, Behzadi E, Pawlak-Adamska EA. Urinary tract infections (UTIs) or genital tract infections (GTIs)? It\u2019s the diagnostics that count. GMS Hyg Infect Control. 2019;14:Doc14. https:\/\/doi.org\/10.3205\/dgkh000320.","journal-title":"GMS Hyg Infect Control"},{"key":"7619_CR3","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1089\/jwh.2020.8811","volume":"30","author":"A Boyd Tressler","year":"2021","unstructured":"Boyd Tressler A, Markwei M, Fortin C, Yao M, Procop GW, Soper DE, et al. Risks for recurrent vulvovaginal candidiasis caused by non-albicans Candida versus Candida albicans. J Womens Health. 2021;30:1588\u201396. https:\/\/doi.org\/10.1089\/jwh.2020.8811.","journal-title":"J Womens Health"},{"key":"7619_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/jof4040121","volume":"4","author":"O Makanjuola","year":"2018","unstructured":"Makanjuola O, Bongomin F, Fayemiwo S. An update on the roles of non-albicans Candida species in vulvovaginitis. J Fungi. 2018;4:17. https:\/\/doi.org\/10.3390\/jof4040121.","journal-title":"J Fungi"},{"key":"7619_CR5","doi-asserted-by":"publisher","first-page":"7721","DOI":"10.24941\/ijcr.36892.10.2019","volume":"11","author":"SF Tovo","year":"2019","unstructured":"Tovo SF, Ouattara A, Yonli AT, Djigma WF. Prevalence of lower genital tract infections in women: case of Saint Camille Hospital of Ouagadougou from 2015 to 2018. Int J Curr Res. 2019;11:7721\u20137. https:\/\/doi.org\/10.24941\/ijcr.36892.10.2019.","journal-title":"Int J Curr Res"},{"key":"7619_CR6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.mycmed.2017.08.006","volume":"28","author":"I Sangar\u00e9","year":"2018","unstructured":"Sangar\u00e9 I, Sirima C, Bamba S, Zida A, Ciss\u00e9 M, Bazi\u00e9 W, et al. Prevalence of vulvovaginal candidiasis in pregnancy at three health centers in Burkina Faso. J Mycol Med. 2018;28:186\u201392. https:\/\/doi.org\/10.1016\/j.mycmed.2017.08.006.","journal-title":"J Mycol Med"},{"key":"7619_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.7324\/JAPS.2017.70131","volume":"7","author":"CW Nadembega","year":"2017","unstructured":"Nadembega CW, Djigma F, Ouermi DDD, Karou SD, Simpore J. Prevalence of vaginal infection in 15 to 24 years women in Ouagadougou, Burkina Faso. J Appl Pharm Sci. 2017;7:209\u201313. https:\/\/doi.org\/10.7324\/JAPS.2017.70131.","journal-title":"J Appl Pharm Sci"},{"key":"7619_CR8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.mycmed.2017.07.001","volume":"27","author":"A Zida","year":"2017","unstructured":"Zida A, Yacouba A, Bambace I, Sangarece M. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso). Med Mycol. 2017;27:469\u201375.","journal-title":"Med Mycol"},{"key":"7619_CR9","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/S0966-842X(03)00117-3","volume":"11","author":"FC Odds","year":"2003","unstructured":"Odds FC, Brown AJP, Gow NAR. Antifungal agents: mechanisms of action. Trends Microbiol. 2003;11:272\u20139. https:\/\/doi.org\/10.1016\/S0966-842X(03)00117-3.","journal-title":"Trends Microbiol"},{"key":"7619_CR10","doi-asserted-by":"publisher","DOI":"10.11604\/PAMJ.2021.38.299.27596","author":"HRS Matotou","year":"2021","unstructured":"Matotou HRS, Sangare I, Bisseye C, Akotet MKB, Bamba S. Biodiversity of isolated fungal flora at the reanimation service of the University Hospital Souro Sanou of Bobo-Dioulasso, Burkina Faso. Pan Afr Med J. 2021. https:\/\/doi.org\/10.11604\/PAMJ.2021.38.299.27596.","journal-title":"Pan Afr Med J"},{"key":"7619_CR11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.5455\/MSM.2013.25.223-225","volume":"25","author":"S Hadzic","year":"2013","unstructured":"Hadzic S, Dedic A, GojkovVukelic M, MehicBasara N, Hukic M, Babic M, et al. The effect of psychoactive substances (drugs) on the presence and frequency of oral Candida species and Candida dubliniensis. Mater Sociomed 2013;25:223. https:\/\/doi.org\/10.5455\/MSM.2013.25.223-225.","journal-title":"Mater Sociomed"},{"key":"7619_CR12","unstructured":"CLSI. Method for antifungal disk diffusion susceptibility testing of yeasts. 3rd ed. CLSI guideline M44. Wayne, PA: Clinical and Laboratory Standards Institute; 2018."},{"key":"7619_CR13","unstructured":"CLSI. Method for antifungal disk diffusion susceptibility testing of yeasts; approved guideline\u2014second edition. CLSI document M44-A2. Wayne, PA: Clinical and Laboratory Standards Institute; 2009."},{"key":"7619_CR14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1590\/S1516-89132012000200020","volume":"55","author":"GA da Silva","year":"2012","unstructured":"da Silva GA, Bernardi TL, Schaker PDC, Menegotto M, Valente P. Rapid yeast DNA extraction by boiling and freeze-thawing without using chemical reagents and DNA purification. Braz Arch Biol Technol. 2012;55:319\u201327. https:\/\/doi.org\/10.1590\/S1516-89132012000200020.","journal-title":"Braz Arch Biol Technol"},{"key":"7619_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/JAMB\/2019\/V18I330174","volume":"18","author":"A Chuku","year":"2019","unstructured":"Chuku A, Yami L, Bukola A, Lanka Reviewers S, Bartzatt R. Prevalence of Candida species from cases of vulvovaginitis in women using contraceptives in four selected states of north Central Nigeria. J Adv Microbiol. 2019;18:1\u201310. https:\/\/doi.org\/10.9734\/JAMB\/2019\/V18I330174.","journal-title":"J Adv Microbiol"},{"key":"7619_CR16","doi-asserted-by":"publisher","first-page":"572","DOI":"10.5897\/ajmr2018.8817","volume":"14","author":"GC Kouadio-Yapo","year":"2020","unstructured":"Kouadio-Yapo GC, Aka NAD, Bonouman-Ira AV, Dou GSP, Sonan KHG, Zika KD, et al. Resistance of Candida albicans to antifungal drugs in Abidjan (Cote dIvoire). Afr J Microbiol Res. 2020;14:572\u20138. https:\/\/doi.org\/10.5897\/ajmr2018.8817.","journal-title":"Afr J Microbiol Res"},{"key":"7619_CR17","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/1567-1364.12042","volume":"13","author":"M-J Xiang","year":"2013","unstructured":"Xiang M-J, Liu J-Y, Ni P-H, Wang S, Shi C, Wei B, et al. Erg11 mutations associated with azole resistance in clinical isolates of Candida albicans. FEMS Yeast Res. 2013;13:386\u201393. https:\/\/doi.org\/10.1111\/1567-1364.12042.","journal-title":"FEMS Yeast Res"},{"key":"7619_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40001-019-0399-0","volume":"25","author":"MT Yassin","year":"2020","unstructured":"Yassin MT, Mostafa AA, Al-Askar AA, Bdeer R. In vitro antifungal resistance profile of Candida strains isolated from Saudi women suffering from vulvovaginitis. Eur J Med Res. 2020;25:9. https:\/\/doi.org\/10.1186\/s40001-019-0399-0.","journal-title":"Eur J Med Res"},{"key":"7619_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12884-020-02963-3","volume":"20","author":"SD Waikhom","year":"2020","unstructured":"Waikhom SD, Afeke I, Kwawu GS, Mbroh HK, Osei GY, Louis B, et al. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates. BMC Pregnancy Childbirth. 2020;20:1\u201314. https:\/\/doi.org\/10.1186\/s12884-020-02963-3.","journal-title":"BMC Pregnancy Childbirth"},{"key":"7619_CR20","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/J.MYCMED.2019.100895","volume":"29","author":"M Bignoumba","year":"2019","unstructured":"Bignoumba M, Onanga R, Bivigou Mboumba B, Gafou A, Mouanga Ndzime Y, Lendamba RW, et al. Vulvovaginal candidiasis among symptomatic women of childbearing age attended at a Medical Analysis Laboratory in Franceville, Gabon. J Mycol Med. 2019;29:317\u20139. https:\/\/doi.org\/10.1016\/J.MYCMED.2019.100895.","journal-title":"J Mycol Med"},{"key":"7619_CR21","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/MYC.12204","volume":"57","author":"JY Zhang","year":"2014","unstructured":"Zhang JY, Liu JH, Liu FD, Xia YH, Wang J, Liu X, et al. Vulvovaginal candidiasis: species distribution, fluconazole resistance and drug efflux pump gene overexpression. Mycoses. 2014;57:584\u201391. https:\/\/doi.org\/10.1111\/MYC.12204.","journal-title":"Mycoses"},{"key":"7619_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.bjm.2016.09.006","volume":"48","author":"TM Brandolt","year":"2017","unstructured":"Brandolt TM, Klafke GB, Gon\u00e7alves CV, Bitencourt LR, de Martinez AMB, Mendes JF, et al. Prevalence of Candida spp. in cervical-vaginal samples and the in vitro susceptibility of isolates. Braz J Microbiol. 2017;48:145\u201350. https:\/\/doi.org\/10.1016\/j.bjm.2016.09.006.","journal-title":"Braz J Microbiol"},{"key":"7619_CR23","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.anaerobe.2011.04.008","volume":"17","author":"V Papaemmanouil","year":"2011","unstructured":"Papaemmanouil V, Georgogiannis N, Plega M, Lalaki J, Lydakis D, Dimitriou M, et al. Prevalence and susceptibility of Saccharomyces cerevisiae causing vaginitis in Greek women. Anaerobe. 2011;17:298\u20139. https:\/\/doi.org\/10.1016\/j.anaerobe.2011.04.008.","journal-title":"Anaerobe"},{"key":"7619_CR24","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1007\/s00248-012-0084-0","volume":"64","author":"R Guo","year":"2012","unstructured":"Guo R, Zheng N, Lu H, Yin H, Yao J, Chen Y. Increased diversity of fungal flora in the vagina of patients with recurrent vaginal candidiasis and allergic rhinitis. Microb Ecol. 2012;64:918\u201327. https:\/\/doi.org\/10.1007\/s00248-012-0084-0.","journal-title":"Microb Ecol"},{"key":"7619_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12688\/f1000research.10327.2","volume":"5","author":"CWJ Africa","year":"2017","unstructured":"Africa CWJ, Abrantes PMDS. Candida antifungal drug resistance in sub-Saharan African populations: a systematic review. F1000Research. 2017;5:1\u20139. https:\/\/doi.org\/10.12688\/f1000research.10327.2.","journal-title":"F1000Research"},{"key":"7619_CR26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2147\/IDR.S118892","volume":"10","author":"EL Berkow","year":"2017","unstructured":"Berkow EL, Lockhart SR. Fluconazole resistance in Candida species: a current perspective. Infect Drug Resist. 2017;10:237\u201345. https:\/\/doi.org\/10.2147\/IDR.S118892.","journal-title":"Infect Drug Resist"},{"key":"7619_CR27","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.13005\/bpj\/1765","volume":"12","author":"KH Das","year":"2019","unstructured":"Das KH, Mangayarkarasi V, Sen M. Antifungal resistant in non-albicans Candida species are emerging as a threat to antenatal women with vulvovaginal candidiasis. Biomed Pharmacol J. 2019;12:1369\u201378. https:\/\/doi.org\/10.13005\/bpj\/1765.","journal-title":"Biomed Pharmacol J"},{"key":"7619_CR28","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/mmy\/myy117","volume":"57","author":"MA Farhan","year":"2019","unstructured":"Farhan MA, Moharram AM, Salah T, Shaaban OM. Types of yeasts that cause vulvovaginal candidiasis in chronic users of corticosteroids. Med Mycol. 2019;57:681\u20137. https:\/\/doi.org\/10.1093\/mmy\/myy117.","journal-title":"Med Mycol"},{"key":"7619_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/isrr\/2019\/v8i230097","volume":"ISRR","author":"AB Abdu","year":"2019","unstructured":"Abdu AB, Alade T, Omotu C. Azole resistance and detection of the ERG11 gene in clinical Candida albicans isolated from pregnant women with vulvovaginitis attending Federal Medical Centre, Yenagoa, Nigeria. Int STD Res Rev. 2019;ISRR:1\u201311. https:\/\/doi.org\/10.9734\/isrr\/2019\/v8i230097.","journal-title":"Int STD Res Rev"},{"key":"7619_CR30","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/J.APJTB.2015.08.002","volume":"5","author":"B Wang","year":"2015","unstructured":"Wang B, Huang L-H, Zhao J-X, Wei M, Fang H, Wang D-Y, et al. ERG11 mutations associated with azole resistance in Candida albicans isolates from vulvovaginal candidosis patients. Asian Pac J Trop Biomed. 2015;5:909\u201314. https:\/\/doi.org\/10.1016\/J.APJTB.2015.08.002.","journal-title":"Asian Pac J Trop Biomed"},{"key":"7619_CR31","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1128\/AAC.46.6.1704","volume":"46","author":"TC White","year":"2002","unstructured":"White TC, Holleman S, Dy F, Laurence F, Stevens Da, Mirels LF. Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob Agents Chemother. 2002;46:1704\u201313. https:\/\/doi.org\/10.1128\/AAC.46.6.1704.","journal-title":"Antimicrob Agents Chemother"},{"key":"7619_CR32","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3855\/JIDC.11102","volume":"13","author":"D Usai","year":"2019","unstructured":"Usai D, Donadu MG, Bua A, Molicotti P, Zanetti S, Piras S, et al. Enhancement of antimicrobial activity of pump inhibitors associating drugs. J Infect Dev Ctries. 2019;13:162\u20134. https:\/\/doi.org\/10.3855\/JIDC.11102.","journal-title":"J Infect Dev Ctries"},{"key":"7619_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.MYCMED.2016.10.002","volume":"27","author":"A Zida","year":"2017","unstructured":"Zida A, Bamba S, Yacouba A, Ouedraogo-Traore R, Guiguemd\u00e9 RT. Anti-Candida albicans natural products, sources of new antifungal drugs: a review. J Mycol Med. 2017;27:1\u201319. https:\/\/doi.org\/10.1016\/J.MYCMED.2016.10.002.","journal-title":"J Mycol Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07619-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07619-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07619-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T13:03:23Z","timestamp":1659963803000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07619-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,8]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["7619"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07619-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,8]]},"assertion":[{"value":"16 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is based on a study that was approved by the Ethics Committee for Health Research of Burkina Faso (CERS) (Ref. N\u00b02017-1026\/MS\/RCEN\/DRSC).  It was approved by the Institutional Ethics Committee of Saint Camille Hospital of Ouagadougou (HOSCO)\/Biomolecular Research Center Pietro Annigoni (CERBA) as necessary administrative permissions to access the raw data\/samples mentioned in the methods. This study does not involve any risk to the health, physical and moral integrity of the participants. The clinical samples were obtained for the present study and the participants were patients received at the HOSCO bacteriology laboratory for routine examinations (vaginal swabs).  Informed consent was obtained from all participants prior to data collection and all methods were carried out in accordance with relevant guidelines and regulations. The sample was then kept anonymous before use. In addition, they have already received their test results and we used the same samples to characterize the antibiotic resistance gene by PCR in order to contribute to their better management.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Standard descriptive analysis was performed using Excel 2016 and IBM SPSS 25.0 (SPSS Inc., Illinois, USA) software. The \u03c7<sup>2<\/sup> test and Fisher\u2019s exact test was used to compare categorical variables and the differences between groups were considered statistically significant for p\u2009\u2264\u20090.05.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistical analyses"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"678"}}